A pairing appears on this page only when a trial gave both ingredients together and measured the result. Tyrosol has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Tyrosol carries a single phenolic hydroxyl and can be converted to the catechol hydroxytyrosol by hydroxylation, which is part of why the two rise and fall together after olive oil intake. Because they are almost never studied separately, most reported effects belong to the pair rather than to tyrosol alone. Hydroxytyrosol is the stronger radical scavenger of the two by virtue of the catechol group.
In olive fruit and leaf the phenols are stored mostly as secoiridoid esters. Ligstroside hydrolyses to give tyrosol and oleuropein gives hydroxytyrosol, and this hydrolysis proceeds during fruit ripening, oil storage and digestion. That is why free tyrosol content in an olive oil climbs as the oil ages while total phenol content falls.
Alpha-tocopherol and the olive phenols both interrupt lipid peroxidation chains, and phenolics can regenerate the tocopheroxyl radical back to tocopherol in model lipid systems. The pairing exists naturally in extra virgin olive oil rather than being a formulation invention. The chemistry is well characterised in vitro, with less direct measurement of the recycling step in people.
Ascorbate sits in the aqueous phase and can reduce phenoxyl radicals formed when a phenol quenches a radical, returning the phenol to its active form. Tyrosol is amphiphilic enough to sit at that interface. This is standard antioxidant network chemistry rather than a claim about a health outcome.
A substantial share of ingested olive secoiridoids reaches the colon intact, where bacteria release the free phenols and convert them further. Reviews of polyphenol and microbiota interaction place tyrosol inside that two-way relationship. What is described is a bidirectional interaction, not a demonstrated benefit of combining the two.
Tyrosol is amphiphilic, more water soluble than most olive phenols but still delivered in nature within an oil. A lipid vehicle mimics the matrix in which the human data on olive phenols was generated. Isolated tyrosol powder in water is a different exposure situation from the same amount inside an oil.
EPA and DHA carry many double bonds and oxidise readily both in the bottle and after absorption. Phenolic antioxidants co-formulated in the oil phase slow that oxidation. The rationale is formulation stability and lipid protection, which is a marker-level argument rather than an outcome-level one.
Ubiquinol works within membranes and lipoproteins where tyrosol and its relatives also partition. Regeneration relationships between lipid-phase antioxidants are established as a class behaviour. The specific tyrosol and ubiquinol pairing has not been characterised.
Squalene and the olive phenols travel together in olive oil and are both concentrated in olive pomace and vegetation water streams. The co-occurrence is a sourcing fact. It is not evidence of a combined biological effect.
Both are small phenols cleared rapidly by sulfation and glucuronidation in the gut wall and liver, and both circulate mainly as conjugates rather than as the free compound. Loading two such phenols together means competition for the same conjugating capacity, which can raise free levels of either. Whether that reaches a meaningful magnitude at supplement intakes has not been measured.
Nothing specific on file for Tyrosol. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 8 we read for Tyrosol. The full linked list is below.
4 sources behind our Tyrosol verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Read this carefully. These are 38 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Tyrosol is, not how risky it is. A report is not proof Tyrosol caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.